CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.


Journal

The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634

Informations de publication

Date de publication:
02 2021
Historique:
received: 22 05 2020
revised: 12 10 2020
accepted: 29 10 2020
pubmed: 4 11 2020
medline: 8 6 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

The CDKN1B gene, encoding for the CDK inhibitor p27

Identifiants

pubmed: 33140857
doi: 10.1002/path.5584
pmc: PMC7839435
doi:

Substances chimiques

CDKN1B protein, human 0
Cyclin-Dependent Kinase Inhibitor p27 147604-94-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-245

Informations de copyright

© 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

Références

Front Endocrinol (Lausanne). 2018 Jul 17;9:393
pubmed: 30065701
Cancer Res. 1996 May 15;56(10):2400-4
pubmed: 8625318
Sci Rep. 2017 Apr 4;7(1):595
pubmed: 28377607
Oncotarget. 2014 Dec 30;5(24):12704-14
pubmed: 25587029
Cancer Discov. 2011 Sep;1(4):326-37
pubmed: 22586611
Int J Cancer. 2010 Dec 15;127(12):2851-8
pubmed: 21351264
Cell. 1996 May 31;85(5):733-44
pubmed: 8646781
PLoS Genet. 2019 Mar 20;15(3):e1008002
pubmed: 30893315
Oncogene. 2016 Sep 15;35(37):4914-26
pubmed: 26876200
Nature. 2012 Jun 10;486(7403):353-60
pubmed: 22722193
BMC Genomics. 2014 Jul 17;15:605
pubmed: 25034939
Cell Cycle. 2014;13(19):3100-11
pubmed: 25486569
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Nature. 2012 May 16;486(7403):400-4
pubmed: 22722201
Cell Stem Cell. 2013 Jul 3;13(1):117-30
pubmed: 23770079
Cancer Res. 2016 Apr 1;76(7):1926-34
pubmed: 26941287
Sci Transl Med. 2019 Aug 14;11(505):
pubmed: 31413145
Breast Cancer Res. 2014 Aug 27;16(4):427
pubmed: 25436920
Science. 2019 Dec 13;366(6471):
pubmed: 31831640
Cancer Res. 2004 Jun 1;64(11):3981-6
pubmed: 15173011
Clin Cancer Res. 2008 Mar 1;14(5):1325-32
pubmed: 18316551
Breast. 2014 Jun;23(3):209-20
pubmed: 24767882
J Cell Biol. 2001 May 28;153(5):917-32
pubmed: 11381079
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
Nature. 1998 Nov 12;396(6707):177-80
pubmed: 9823898
Nucleic Acids Res. 2000 Jan 1;28(1):352-5
pubmed: 10592272
Front Horm Res. 2013;41:63-78
pubmed: 23652671
Cancer Res. 2019 Jan 15;79(2):397-409
pubmed: 30478213
Mol Cell Biol. 2008 Jan;28(1):258-68
pubmed: 17954563
Mol Diagn. 2005;9(1):17-21
pubmed: 16035731
J Clin Oncol. 2003 Oct 1;21(19):3594-600
pubmed: 14512390
Cancer Res. 2020 Mar 1;80(5):1064-1077
pubmed: 31862778
PLoS One. 2020 May 6;15(5):e0231999
pubmed: 32374727
Cell Div. 2019 Apr 1;14:2
pubmed: 30976290
Nat Genet. 2012 May 20;44(6):685-9
pubmed: 22610119
Nat Genet. 2013 Dec;45(12):1483-6
pubmed: 24185511

Auteurs

Davide Viotto (D)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Francesca Russo (F)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
University of Trieste, Trieste, Italy.

Ilaria Anania (I)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Ilenia Segatto (I)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Gian Luca Rampioni Vinciguerra (GL)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
Department of Clinical and Molecular Medicine, University of Rome 'Sapienza', Sant'Andrea Hospital, Rome, Italy.

Alessandra Dall'Acqua (A)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Riccardo Bomben (R)

Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Tiziana Perin (T)

Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Martina Cusan (M)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Monica Schiappacassi (M)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Lorenzo Gerratana (L)

Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
Department of Medicine (DAME), University of Udine, Udine, Italy.

Sara D'Andrea (S)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Francesca Citron (F)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Filippo Vit (F)

University of Trieste, Trieste, Italy.
Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Lorena Musco (L)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
University of Trieste, Trieste, Italy.

Maria Chiara Mattevi (MC)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Giorgia Mungo (G)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Milena S Nicoloso (MS)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Maura Sonego (M)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Samuele Massarut (S)

Breast Surgery Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Roberto Sorio (R)

Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Luigi Barzan (L)

Division of Otorhinolaryngology, General Hospital of Pordenone Santa Maria degli Angeli, Pordenone, Italy.

Giovanni Franchin (G)

Radiotherapy Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Giorgio Giorda (G)

Gynecological Surgery Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Emilio Lucia (E)

Gynecological Surgery Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Sandro Sulfaro (S)

Unit of Pathology, General Hospital of Pordenone Santa Maria degli Angeli, Pordenone, Italy.

Vittorio Giacomarra (V)

Division of Otorhinolaryngology, General Hospital of Pordenone Santa Maria degli Angeli, Pordenone, Italy.

Jerry Polesel (J)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Federica Toffolutti (F)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Vincenzo Canzonieri (V)

Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.

Fabio Puglisi (F)

Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.
Department of Medicine (DAME), University of Udine, Udine, Italy.

Valter Gattei (V)

Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Andrea Vecchione (A)

Department of Clinical and Molecular Medicine, University of Rome 'Sapienza', Sant'Andrea Hospital, Rome, Italy.

Barbara Belletti (B)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Gustavo Baldassarre (G)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute, Aviano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH